SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is generating significant community buzz, with conversation centering on its robust utility as an AI agent token and recent major exchange listings. Enthusiasm is high for its potential within the Coinbase Base ecosystem, leading many to advocate for buying dips amidst some concern over its inherent volatility.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is actively discussed as its community anticipates the upcoming 4/20 cultural event and potential cannabis rescheduling, rallying around its mission to support global legalization and integrate real-world utility. Despite some market skepticism, many holders are focused on the "Bongterm" vision and its identity as "like Bitcoin but way higher" within the Solana ecosystem.

SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.

SpyGlass Pharma Inc.

SpyGlass Pharma (SGP) is trending with a surge in community interest and watchlist placements, as investors eagerly anticipate a potential move, fueled by recent analytical content circulating online.

HeavyPulp

The crypto token HEAVYPULP is gaining traction due to its narrative as a community-driven takeover by the artist, sparking discussions about its potential as a "creator capital market" project. While some see it as an easy play with significant upside given the artist's involvement, others warn of it being a pump and dump.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

Halozyme Therapeutics is trending as a German injunction against Merck's Keytruda SC bolsters optimism for substantial MDASE licensing revenue, further fueled by robust preliminary 2025/2026 financial guidance and the welcomed withdrawal of its Evotec acquisition proposal, with the community actively highlighting its perceived undervaluation.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending due to its breakthrough AI-driven autonomous lab, developed with OpenAI, which demonstrated a 40% cost reduction in cell-free protein synthesis. This has sparked community discussions about its potential as a transformative "platform business" in synthetic biology, further fueled by increased institutional interest and government initiatives in biosecurity and AI.

CLAWNCH

CLAWNCH is a rapidly trending new crypto on the BASE ecosystem, gaining significant attention from recent exchange listings and rising to a top trending spot, sparking community discussion about its potential as an 'AI agent' project while some caution it's a speculative 'pump and dump'.

IPG Photonics Corp. engages in the provision of design, development, production and distribution of fiber lasers, laser systems, fiber amplifiers, and related optical components. Its products include lasers, beam delivery, medical, telecom equipment, product finder and components such as pump diodes, chillers, and mid-IR crystals. The company was founded by Valentin P. Gapontsev and Igor Samartsev in 1990 and is headquartered in Marlborough, MA.

IPG Photonics Corp

IPG Photonics is trending as investors consider its strategic shift, including recent acquisitions in laser cleaning and divestiture of telecom lines, alongside varied but improving earnings reports. The community is buzzing about its fiber laser technology's potential in growing sectors like materials processing, medical, defense, and the broader high-speed optics demand driven by AI.

WisdomTree, Inc. engages in the provision of a diversified suite of exchange traded products (ETP), models, solutions, and products leveraging blockchain technology. It also develops digital or blockchain-enabled mutual funds and tokenized assets, as well as blockchain-native digital wallet, under the name of WisdomTree Prime. The company was founded by Jonathan Laurence Steinberg on September 19, 1985 and is headquartered in New York, NY.

WisdomTree Inc

WisdomTree is trending due to consistent strong financial performance and its pivotal role in digital asset innovation, highlighted by the launch of its Bitcoin ETF and regulatory advancements for its blockchain-enabled platforms, fueling community sentiment that the stock is currently undervalued.

Ivanhoe Mines Ltd. - Ordinary Shares - Class A

Ivanhoe Mines is trending amid recent positive operational updates highlighting strong fundamentals and significant future copper production capacity, with many investors believing the stock remains undervalued despite past underperformance relative to soaring copper prices. The community is actively discussing its world-class, high-grade assets and strategic leadership as key factors for its long-term potential in the essential copper market, balanced against some geopolitical considerations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nuvectis Pharma (NASDAQ:NVCT) Trading Up 5.8% - Should You Buy?

Nuvectis Pharma (NASDAQ:NVCT) Stock Price Up 5.8% - Should You Buy...

Nuvectis Pharma (NASDAQ:NVCT) Stock Price Up 0.5% - Here's Why

Nuvectis Pharma (NASDAQ:NVCT) Stock Price Up 0.5% - What's Next...

Nuvectis Pharma (NASDAQ:NVCT) Trading 9.8% Higher - Here's What Happened

Nuvectis Pharma (NASDAQ:NVCT) Shares Up 9.8% - Here's What Happened...

Matthew Kaplan Acquires 11,000 Shares of Nuvectis Pharma (NASDAQ:NVCT) Stock

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) Director Matthew Kaplan purchased 11,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 5th. The stock was...

Nuvectis Pharma (NASDAQ:NVCT) CEO Buys $28,600.00 in Stock

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) CEO Ron Bentsur purchased 5,000 shares of the company's stock in a transaction that occurred on Wednesday, November 5th. The stock was acquired...

Nuvectis Pharma (NASDAQ:NVCT) Director Buys $75,270.00 in Stock

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) Director Juan Sanchez purchased 13,000 shares of the firm's stock in a transaction on Wednesday, November 5th. The shares were acquired at an...

Nuvectis Pharma FY2029 EPS Forecast Lifted by Roth Capital

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) - Analysts at Roth Capital increased their FY2029 earnings estimates for shares of Nuvectis Pharma in a note issued to investors on Tuesday, November...

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Nuvectis Pharma Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

NVCT
Nuvectis Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NVCT News

NVCTNuvectis Pharma Inc